Literature DB >> 22173757

Differentiation of tumefactive demyelinating lesions from high-grade gliomas with the use of diffusion tensor imaging.

C H Toh1, K-C Wei, S-H Ng, Y-L Wan, M Castillo, C-P Lin.   

Abstract

BACKGROUND AND
PURPOSE: TDLs may be indistinguishable from high-grade gliomas on conventional MR imaging. The role of DTI in differentiating TDLs from high-grade gliomas is not clear, and quantitative comparison between the 2 has not been reported. Here we aimed to differentiate TDLs from high-grade gliomas by using DTI.
MATERIALS AND METHODS: DTI was performed in 8 TDLs and 13 high-grade gliomas. The presence of 3 findings (ie, intralesional hyperintensities on the FA map, restricted diffusion in the lesion periphery, and a perilesional hyperintense FA rim) was assessed by visual inspection. The FA and MD values were measured in the central nonenhancing portion, peripheral enhancing portion, and perilesional edema for each lesion and compared between the 2 groups respectively.
RESULTS: TDLs had a significantly higher incidence of intralesional hyperintensities on FA maps (P = .049) but a lower incidence of a perilesional hyperintense FA rim (P < .001), compared with those of high-grade gliomas on visual inspection. TDLs had significantly higher FA (P = .004) and lower MD (P = .001) values in the peripheral enhancing portions of the lesions compared with those of high-grade gliomas. In perilesional edema, FA values were significantly higher in high-grade gliomas (P = .001).
CONCLUSIONS: DTI is helpful in differentiating TDLs from high-grade gliomas by using visual inspection and quantitative analysis.

Entities:  

Mesh:

Year:  2011        PMID: 22173757      PMCID: PMC7968810          DOI: 10.3174/ajnr.A2871

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  27 in total

Review 1.  The MRI appearance of tumefactive demyelinating lesions.

Authors:  Curtis A Given; B Scott Stevens; Charles Lee
Journal:  AJR Am J Roentgenol       Date:  2004-01       Impact factor: 3.959

2.  Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy.

Authors:  H S Malhotra; K K Jain; A Agarwal; M K Singh; S K Yadav; M Husain; N Krishnani; R K Gupta
Journal:  Mult Scler       Date:  2009-02       Impact factor: 6.312

3.  Fractional anisotropy and tumor cell density of the tumor core show positive correlation in diffusion tensor magnetic resonance imaging of malignant brain tumors.

Authors:  Manabu Kinoshita; Naoya Hashimoto; Tetsu Goto; Naoki Kagawa; Haruhiko Kishima; Shuichi Izumoto; Hisashi Tanaka; Norihiko Fujita; Toshiki Yoshimine
Journal:  Neuroimage       Date:  2008-07-11       Impact factor: 6.556

4.  Is diffusion anisotropy an accurate monitor of myelination? Correlation of multicomponent T2 relaxation and diffusion tensor anisotropy in human brain.

Authors:  Burkhard Mädler; Sylvia A Drabycz; Shannon H Kolind; Kenneth P Whittall; Alexander L MacKay
Journal:  Magn Reson Imaging       Date:  2008-06-04       Impact factor: 2.546

Review 5.  Tumefactive demyelinating lesions.

Authors:  A P Dagher; J Smirniotopoulos
Journal:  Neuroradiology       Date:  1996-08       Impact factor: 2.804

6.  Diffusion tensor MR imaging of cerebral gliomas: evaluating fractional anisotropy characteristics.

Authors:  M L White; Y Zhang; F Yu; S A Jaffar Kazmi
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-14       Impact factor: 3.825

Review 7.  Applications of diffusion tensor MR imaging in multiple sclerosis.

Authors:  Yulin Ge; Meng Law; Robert I Grossman
Journal:  Ann N Y Acad Sci       Date:  2005-12       Impact factor: 5.691

8.  Multiple sclerosis: remyelination in acute lesions.

Authors:  C S Raine; E Wu
Journal:  J Neuropathol Exp Neurol       Date:  1993-05       Impact factor: 3.685

9.  Differentiation between classic and atypical meningiomas with use of diffusion tensor imaging.

Authors:  C-H Toh; M Castillo; A M-C Wong; K-C Wei; H-F Wong; S-H Ng; Y-L Wan
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

10.  Demyelinating disease versus tumor in surgical neuropathology. Clues to a correct pathological diagnosis.

Authors:  D Zagzag; D C Miller; G M Kleinman; A Abati; H Donnenfeld; G N Budzilovich
Journal:  Am J Surg Pathol       Date:  1993-06       Impact factor: 6.394

View more
  7 in total

Review 1.  Differential imaging of atypical demyelinating lesions of the central nervous system.

Authors:  Matteo Paoletti; Shaun Ivan Muzic; Francesca Marchetti; Lisa Maria Farina; Stefano Bastianello; Anna Pichiecchio
Journal:  Radiol Med       Date:  2021-01-24       Impact factor: 3.469

2.  Diagnostic utility of diffusion tensor imaging in differentiating glioblastomas from brain metastases.

Authors:  S Wang; S J Kim; H Poptani; J H Woo; S Mohan; R Jin; M R Voluck; D M O'Rourke; R L Wolf; E R Melhem; S Kim
Journal:  AJNR Am J Neuroradiol       Date:  2014-02-06       Impact factor: 3.825

3.  Assessment of angiographic vascularity of meningiomas with dynamic susceptibility contrast-enhanced perfusion-weighted imaging and diffusion tensor imaging.

Authors:  C H Toh; K-C Wei; C N Chang; Y-W Peng; S-H Ng; H-F Wong; C-P Lin
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-25       Impact factor: 3.825

4.  Combining Diffusion Tensor Metrics and DSC Perfusion Imaging: Can It Improve the Diagnostic Accuracy in Differentiating Tumefactive Demyelination from High-Grade Glioma?

Authors:  S B Hiremath; A Muraleedharan; S Kumar; C Nagesh; C Kesavadas; M Abraham; T R Kapilamoorthy; B Thomas
Journal:  AJNR Am J Neuroradiol       Date:  2017-02-16       Impact factor: 3.825

5.  Demyelinating lesions behaving like aggressive tumours on advanced MRI techniques.

Authors:  Brainner Campos Barbosa; Edson Marchiori; Caio Leal Leidersnaider; Lara Brandao; Mauricio Castillo
Journal:  Neuroradiol J       Date:  2019-01-22

6.  Tumefactive multiple sclerosis versus high-grade glioma: A diagnostic dilemma.

Authors:  Heath David French
Journal:  Surg Neurol Int       Date:  2021-05-03

7.  Tumefactive multiple sclerosis versus high grade glioma: A diagnostic dilemma.

Authors:  Heath French; Ariadna Fontes-Villalba; Monish Maharaj; Catherine Soo Yee Naidoo; Kartik Bhatia; Amanda Paterson; Raymond Cook; John Parratt
Journal:  Surg Neurol Int       Date:  2022-04-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.